LYMPHOMA, MANTLE CELL
Clinical trials for LYMPHOMA, MANTLE CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted combo aims to slow mantle cell lymphoma
Disease control OngoingThis phase 3 trial tests whether adding the targeted drug acalabrutinib to standard chemotherapy (bendamustine and rituximab) helps people with untreated mantle cell lymphoma live longer without their cancer getting worse. About 635 patients aged 65 and older are taking part. The…
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: PHASE3 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for blood cancer patients: experimental drug takes on standard therapy
Disease control OngoingThis study tests a new drug called pirtobrutinib against other approved drugs for mantle cell lymphoma, a type of blood cancer. About 500 people who have already had at least one prior treatment will take part. The goal is to see if the new drug works better at controlling the di…
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in 316 adults with advanced blood cancers like leukemia, lymphoma, or multiple myeloma. Participants have already tried standard treatments. The main goals are to find the safest dose and see if the drug shrinks tu…
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a smart patch predict dangerous immune reactions in cancer treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether a wearable patch called TempTraq can detect fevers earlier than standard temperature checks in cancer patients receiving immunotherapy. The goal is to see if continuous monitoring reduces the risk of severe cytokine release syndrome (CRS), a serious side …
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
15-Year watch begins for CAR t cell therapy patients
Knowledge-focused OngoingThis study follows 50 people who have already received an experimental CAR T cell therapy for certain blood cancers like lymphoma. No new treatment is given; instead, researchers will check for long-term side effects and how well the therapy works over 15 years. The goal is to be…
Matched conditions: LYMPHOMA, MANTLE CELL
Sponsor: Adicet Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC